An expert opinion on esophageal cancer therapy (Q37827871)

23 August 2017

1 reference

title

An expert opinion on esophageal cancer therapy (English)

1 reference

23 August 2017

1 reference

2

Jaffer Ajani

1 reference

23 August 2017

Deirdre J Cohen

1

1 reference

PubMed ID

21226634

23 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

Expert Opinion on Pharmacotherapy

23 August 2017

1 reference

23 August 2017

12

1 reference

23 August 2017

2

1 reference

23 August 2017

225-239

1 reference

Global cancer statistics, 2002

23 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Adenocarcinoma of the esophagus: role of obesity and diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Symptomatic gastroesophageal reflux: incidence and precipitating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Risk factors for esophageal cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Section III: endoscopic and other staging techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Staging investigations for oesophageal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

The "best operation" for esophageal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Worldwide esophageal cancer collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Vascular endothelial growth factor in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Esophagogastric cancer: targeted agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Future developments in esophageal cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.517748

10.1517/14656566.2010.517748

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21226634